Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis

Bernardo, Wanderley Marques; Aires, Felipe Toyama; Carneiro, Renata Mota; Sá, Fernando Pereira de; Rullo, Vera Esteves Vagnozzi; Burns, Dennis Alexander

doi:10.1016/j.jpedp.2012.09.001

Informação do artigo

Abstract

Objective

To elucidate the benefits of using probiotics in the prevention of necrotizing enterocolitis (NEC) and its complications in preterm newborns.

Method

This was a systematic review of randomized controlled trials, which included studies retrieved from three databases (MEDLINE, Embase, and LILACS), using a combination of the terms (necrotizing enterocolitis) AND (probiotics).

Results

11 randomized trials were included, totaling 2,887 patients, 1,431 in the probiotic group and 1,456 in the control group. There was a reduction in the incidence of NEC (NNT=25), overall death (NNT=34), and neonatal sepsis (NNT=34) in the probiotic group compared to the control group. Patients that received probiotic supplementation had lower food reintroduction time (p<0.001) and hospitalization time (p<0.001) when compared to those not receiving probiotics. There was no difference in mortality caused by NEC.

Conclusion

In premature newborns, the use of probiotics is effective as a prophylaxis for NEC and its complications.

Keywords:

Home oxygen therapy

Children

Oxygen

Resumo

Objetivo

Elucidar os benefícios do uso de probióticos na prevenção de enterocolite necrosante (ECN) e de suas complicações em recém-nascidos prematuros.

Método

Revisão sistemática de ensaios clínicos randomizados, que incluiu pesquisas efetuadas em três bases de dados (MEDLINE, EMBASE e LILACS), utilizando a combinação dos termos (necrotizing enterocolitis) AND (probiotics).

Resultados

Foram incluídos 11 ensaios clínicos randomizados, totalizando 2.887 pacien- tes, sendo 1.431 no grupo Probiótico e 1.456 no grupo Controle. Houve redução na incidência de ECN (NNT=25), de morte global (NNT=34) e sepse neonatal (NNT=34) no grupo Probiótico em relação ao grupo Controle. Pacientes alimentados com suple- mentação de probióticos tiveram tempo de reintrodução alimentar (p<0,001) e de hospitalização (p<0,001) menor quando comparados aos que não receberam. Não houve diferença na mortalidade causada por ECN.

Conclusão

Em recém-nascidos prematuros, o uso de probióticos é eficaz na profilaxia de ECN e de suas complicações.

Palavras-chave:

Enterocolite necrosante

Probióticos

Prematuros

O texto completo está disponível em PDF

References

[1]

I. Brook.

Microbiology and management of neonatal necrotizing enterocolitis.

Am J Perinatol., 25 (2008), pp. 111-118

http://dx.doi.org/10.1055/s-2008-1040346 | Medline

[2]

R.M. Reynolds, P.J. Thureen.

Special circumstances: trophic feeds, necrotizing enterocolitis and bronchopulmonary dysplasia.

Semin Fetal Neonatal Med., 12 (2007), pp. 64-70

http://dx.doi.org/10.1016/j.siny.2006.11.002 | Medline

[3]

N.D. de Oliveira, M.H. Miyoshi.

Avanços em enterocolite necrosante.

J Pediatr (Rio J)., 81 (2005), pp. S16-S22

[4]

M.J. Kullen, J. Bettler.

The delivery of probiotics and prebiotics to infants.

Curr Pharm Des., 11 (2005), pp. 55-74

Medline

[5]

M.R. Stenger, K.M. Reber, P.J. Giannone, C.A. Nankervis.

Probiotics and prebiotics for the prevention of necrotizing enterocolitis.

Curr Infect Dis Rep., 13 (2011), pp. 13-20

http://dx.doi.org/10.1007/s11908-010-0156-6 | Medline

[6]

J.C. Arciero, G.B. Ermentrout, J.S. Upperman, Y. Vodovotz, J.E. Rubin.

Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis.

PLoS One., 5 (2010), pp. e10066

http://dx.doi.org/10.1371/journal.pone.0010066 | Medline

[7]

M.J. Bell, J.L. Ternberg, R.D. Feigin, J.P. Keating, R. Marshall, L. Barton, et al.

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.

Ann Surg., 187 (1978), pp. 1-7

Medline

[8]

A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, et al.

Assessing the quality of reports of randomized clinical trials: is blinding necessary?.

Control Clin Trials., 17 (1996), pp. 1-12

Medline

[9]

D. Moher, K.F. Schulz, D.G. Altman.

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Lancet., 357 (2001), pp. 1191-1194

Medline

[10]

P.D. Reuman, D.H. Duckworth, K.L. Smith, R. Kagan, R.L. Bucciarelli, E.M. Ayoub.

Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants.

Pediatr Infect Dis., 5 (1986), pp. 663-668

Medline

[11]

M.R. Millar, C. Bacon, S.L. Smith, V. Walker, M.A. Hall.

Enteral feeding of premature infants with Lactobacillus GG.

Arch Dis Child., 69 (1993), pp. 483-487

Medline

[12]

C. Dani, R. Biadaioli, G. Bertini, E. Martelli, F.F. Rubaltelli.

Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study.

Biol Neonate., 82 (2002), pp. 103-108

http://dx.doi.org/63096 | Medline

[13]

C. Costalos, V. Skouteri, A. Gounaris, S. Sevastiadou, A. Triandafilidou, C. Ekonomidou, et al.

Enteral feeding of premature infants with Saccharomyces boulardii.

Early Hum Dev., 74 (2003), pp. 89-96

Medline

[14]

Y. Li, T. Shimizu, A. Hosaka, N. Kaneko, Y. Ohtsuka, Y. Yamashiro.

Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants.

Pediatr Int., 46 (2004), pp. 509-515

http://dx.doi.org/10.1111/j.1442-200x.2004.01953.x | Medline

[15]

A. Bin-Nun, R. Bromiker, M. Wilschanski, M. Kaplan, B. Rudensky, M. Caplan, et al.

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

J Pediatr., 147 (2005), pp. 192-196

http://dx.doi.org/10.1016/j.jpeds.2005.03.054 | Medline

[16]

H.C. Lin, B.H. Su, A.C. Chen, T.W. Lin, C.H. Tsai, T.F. Yeh, et al.

Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants.

Pediatrics., 115 (2005), pp. 1-4

http://dx.doi.org/10.1542/peds.2004-1463 | Medline

[17]

P. Manzoni, M. Mostert, M.L. Leonessa, C. Priolo, D. Farina, C. Monetti, et al.

Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.

Clin Infect Dis., 42 (2006), pp. 1735-1742

http://dx.doi.org/10.1086/504324 | Medline

[18]

R. Mohan, C. Koebnick, J. Schildt, S. Schmidt, M. Mueller, M. Possner, et al.

Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study.

J Clin Microbiol., 44 (2006), pp. 4025-4031

http://dx.doi.org/10.1128/JCM.00767-06 | Medline

[19]

Z. Stratiki, C. Costalos, S. Sevastiadou, O. Kastanidou, M. Skouroliakou, A. Giakoumatou, et al.

The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants.

Early Hum Dev., 83 (2007), pp. 575-579

http://dx.doi.org/10.1016/j.earlhumdev.2006.12.002 | Medline

[20]

H.C. Lin, C.H. Hsu, H.L. Chen, M.Y. Chung, J.F. Hsu, R.I. Lien, et al.

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial.

Pediatrics., 122 (2008), pp. 693-700

http://dx.doi.org/10.1542/peds.2007-3007 | Medline

[21]

P. Manzoni, M. Rinaldi, S. Cattani, L. Pugni, M.G. Romeo, H. Messner, et al.

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.

JAMA., 302 (2009), pp. 1421-1428

http://dx.doi.org/10.1001/jama.2009.1403 | Medline

[22]

C. Rougé, H. Piloquet, M.J. Butel, B. Berger, F. Rochat, L. Ferraris, et al.

Oral supplementation with probiotics in very-low-birth- weight preterm infants: a randomized, double-blind, placebo- controlled trial.

Am J Clin Nutr., 89 (2009), pp. 1828-1835

http://dx.doi.org/10.3945/ajcn.2008.26919 | Medline

[23]

M. Samanta, M. Sarkar, P. Ghosh, J. Ghosh, M. Sinha, S. Chatterjee.

Prophylactic probiotics for prevention of necrotizing ente-rocolitis in very low birth weight newborns.

J Trop Pediatr., 55 (2009), pp. 128-131

http://dx.doi.org/10.1093/tropej/fmn091 | Medline

[24]

W.A. Mihatsch, S. Vossbeck, B. Eikmanns, J. Hoegel, F. Pohlandt.

Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial.

Neonatology., 98 (2010), pp. 156-163

http://dx.doi.org/10.1159/000280291 | Medline

[25]

H. Awad, H. Mokhtar, S.S. Imam, G.I. Gad, H. Hafez, N. Aboushady.

Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates.

Pak J Biol Sci., 13 (2010), pp. 253-262

Medline

[26]

T.D. Braga, G.A. da Silva, P.I. de Lira, M. de Carvalho Lima.

Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth- weight preterm infants: a double-blind, randomized, controlled trial.

Am J Clin Nutr., 93 (2011), pp. 81-86

http://dx.doi.org/10.3945/ajcn.2010.29799 | Medline

[27]

F.N. Sari, E.A. Dizdar, S. Oguz, O. Erdeve, N. Uras, U. Dilmen.

Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial.

Eur J Clin Nutr., 65 (2011), pp. 434-439

http://dx.doi.org/10.1038/ejcn.2010.278 | Medline

[28]

H. Kitajima, Y. Sumida, R. Tanaka, N. Yuki, H. Takayama, M. Fujimura.

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial.

Arch Dis Child Fetal Neonatal Ed., 76 (1997), pp. F101-F107

Medline

[29]

M.A. Underwood, N.H. Salzman, S.H. Bennett, M. Barman, D.A. Mills, A. Marcobal, et al.

A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short- chain fatty acids.

J Pediatr Gastroenterol Nutr., 48 (2009), pp. 216-225

http://dx.doi.org/10.1097/MPG.0b013e31818de195 | Medline

[30]

D. Ke, Z. Su, L. Li.

Control study on preventing necrotizing enterocolitis in 438 premature infants by using Bifico.

Chin Pediatr Emerg Med., 15 (2008), pp. 69-71

[31]

B. Huang, H. Yang, X. Huang.

Prevention and cure effect of micro ecosystem praeparatum on necrotizing enter ocolitis of very low birth weight infant.

J Guangdong Med Coll., 27 (2009), pp. 37-39

[32]

M. Di, X. Li.

Effects of Bifidobacterium supplementation for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled trial.

Zhong Guo She Qu Yi Shi., 231 (2010), pp. 69

[33]

B. Ren.

Preventive effect of Bifidobacterium tetravaccine tablets in premature infants with necrotizing enterocolitis.

J Pediatr Pharm., 16 (2010), pp. 24-25

[34]

K. Alfaleh, J. Anabrees, D. Bassler, T. Al-Kharfi.

Probiotics for prevention of necrotizing enterocolitis in preterm infants.

Cochrane Database Syst Rev., (2011), pp. CD005496

[35]

G. Deshpande, S. Rao, S. Patole, M. Bulsara.

Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates.

Pediatrics., 125 (2010), pp. 921-930

http://dx.doi.org/10.1542/peds.2009-1301 | Medline

[36]

Q. Wang, J. Dong, Y. Zhu.

Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low- birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials.

J Pediatr Surg., 47 (2012), pp. 241-248

http://dx.doi.org/10.1016/j.jpedsurg.2011.09.064 | Medline

[37]

L. Young, J. Morgan, W. McGuire.

Preventing necrotizing enterocolitis in very low birth weight infants: current evidence.

Paediatrics and Child Health, 21 (2011), pp. 258-264

☆

Please, cite this article as: Adde FV, Alvarez AE, Barbisan BN, Guimarães BR. Recommendations for long-term home oxygen therapy in children and adolescents. J Pediatr (Rio J). 2013;89:6–17.

Indexada em:

Siga-nos:

Indexada em:

Siga-nos:

Receba a nossa Newsletter